Collectively, our results characterized a suppression of CRC proliferation via DIRAS2 by blocking NF-κB signaling and revealed that degradation of DIRAS2 was engendered by PSMD2 in a proteasome-mediated way. This evidence concerns the gene DIRAS2 and colorectal carcinoma.